Salar Pashangzadeh Selected Research

Salar Pashangzadeh Research Topics

Disease

7	Neoplasms (Cancer) 12/2022 - 01/2021
4	Inflammation (Inflammations) 01/2024 - 04/2022
3	COVID-19 02/2023 - 01/2021
2	Infections 02/2023 - 08/2022
2	Fibrosis (Cirrhosis) 10/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2021
2	Primary Immunodeficiency Diseases 01/2020 - 01/2020
1	Colitis 01/2024
1	Crohn Disease (Crohn's Disease) 01/2024
1	Rheumatoid Arthritis 04/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Hepatitis 01/2022
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 07/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2021
1	Hematologic Diseases (Blood Diseases) 06/2021
1	Colonic Neoplasms (Colon Cancer) 06/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 01/2021
1	Infertility (Sterility) 10/2020
1	Common Variable Immunodeficiency 01/2020
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2024 - 04/2022
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2021
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2022 - 01/2021
2	Hormones (Hormone)IBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 06/2021 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2020
1	Recombinant ProteinsIBA 01/2024
1	SolutionsIBA 01/2024
1	CathepsinsIBA 01/2024
1	PeroxiredoxinsIBA 01/2024
1	AcidsIBA 01/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022
1	Connective Tissue Growth FactorIBA 10/2022
1	Endothelin-1 (Endothelin 1)IBA 10/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2022
1	plumbaginIBA 10/2022
1	CollagenIBA 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	Viral DNAIBA 08/2022
1	Hepatitis B e AntigensIBA 08/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	C-Reactive ProteinIBA 04/2022
1	Triglycerides (Triacylglycerol)IBA 04/2022
1	SteroidsIBA 01/2022
1	FurinIBA 12/2021
1	atezolizumabIBA 07/2021
1	avelumabIBA 07/2021
1	tremelimumabIBA 07/2021
1	pembrolizumabIBA 07/2021
1	IpilimumabIBA 07/2021
1	NivolumabIBA 07/2021
1	Immune Checkpoint InhibitorsIBA 07/2021
1	AntibodiesIBA 07/2021
1	Monoclonal AntibodiesIBA 07/2021
1	VitaminsIBA 06/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2021
1	Artificial ReceptorsIBA 06/2021
1	axicabtagene ciloleucelIBA 06/2021
1	tisagenlecleucelIBA 06/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	EnzymesIBA 01/2021
1	Progesterone FDA LinkGeneric 01/2021
1	AutoantigensIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2021

Therapy/Procedure

5	Immunotherapy 12/2022 - 10/2020
3	Therapeutics 02/2023 - 01/2021
1	Tattooing 01/2022
1	Drug Therapy (Chemotherapy) 06/2021
1	Hematopoietic Stem Cell Transplantation 01/2021